{
    "name": "sirolimus protein bound",
    "comment": "Rx",
    "other_names": [
        "Fyarro"
    ],
    "classes": [
        "Antineoplastics",
        "mTOr Kinase Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/fyarro-sirolimus-protein-bound-4000258",
    "pregnancy": {
        "common": [
            "Based on animal studies and the mechanism of action, can cause fetal harm when administered to pregnant females",
            "Verify pregnancy status of females of reproductive potential before initiating"
        ],
        "specific": [
            {
                "type": "Animal studies",
                "description": [
                    "Studies with oral sirolimus formulation have shown that it crosses the placenta and is toxic to the conceptus at subtherapeutic doses"
                ]
            },
            {
                "type": "Contraception",
                "description": [
                    "Females or males with female partners of reproductive potential: Use effective contraception during treatment and for 12 weeks after last dose"
                ]
            },
            {
                "type": "Infertility",
                "description": [
                    "Based on available clinical findings with oral sirolimus and findings in animals, male and female fertility may be compromised",
                    "Ovarian cysts and menstrual disorders (including amenorrhea and menorrhagia) reported in females with the use of oral sirolimus",
                    "Azoospermia reported in males with the use of oral sirolimus and has been reversible upon discontinuation in most cases "
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Data are not available on presence in human milk or its effects on breastfed children or milk production",
            "Unknown if present in human milk",
            "Advise females not to breastfeed during treatment and for 2 weeks after last dose"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "History of severe hypersensitivity to sirolimus, other rapamycin derivatives, or albumin"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "See dosage modifications for recommendations to withhold treatment, reduce dose, or permanently discontinue",
                "Stomatitis, including mouth ulcers and oral mucositis, reported most often within 8 weeks of treatment",
                "May cause myelosuppression, including anemia, thrombocytopenia, and neutropenia",
                "Can cause infections; common infections reported in clinical trials included urinary tract infections, upper respiratory tract infections, and sinusitis",
                "Can cause hypokalemia; potassium supplementation may be indicated",
                "Hyperglycemia may occur in nondiabetic or diabetic patients",
                "Interstitial lung disease/noninfectious pneumonitis reported",
                "Can cause serious and sometimes fatal hemorrhage",
                "Hypersensitivity reactions (to sirolimus or albumin) reported (eg, anaphylaxis, angioedema, exfoliative dermatitis, hypersensitivity vasculitis)",
                "Based on animal studies and mechanism of action, can cause fetal harm when administered to pregnant females",
                "Sirolimus is an antiproliferative drug and affects rapidly dividing cells (eg, as germ cells); azoospermia or oligospermia may be observed in males"
            ],
            "specific": [
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "Substrate of both CYP3A4 and p-gp",
                        "CYP3A4 and/or P-gp inhibitors ",
                        "Strong CYP3A4 and/or P-gp inhibitors: Avoid coadministration",
                        "Moderate or weak CYP3A4 inhibitors: Reduce sirolimus dose",
                        "CYP3A4 and/or P-gp inducers",
                        "Strong CYP3A4 and/or P-gp inducers: Avoid coadministration",
                        "Moderate or weak CYP3A4 inducers: Coadministration may decrease sirolimus efficacy",
                        "Vaccines",
                        "No studies in conjunction with immunization conducted",
                        "Immunization during treatment may be ineffective",
                        "Update immunizations according to immunization guidelines before initiating siroliumus, if possible",
                        "Live vaccines: Immunization with live vaccines is not recommended during treatment and avoid close contact with those who have received live vaccines while taking sirolimus",
                        "Interval between live vaccinations and initiating sirolimus should be in accordance with current ",
                        "vaccination guidelines",
                        " for patients on immunosuppressive therapies"
                    ]
                }
            ]
        }
    },
    "interactions": [
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "omaveloxolone",
            "description": {
                "common": "omaveloxolone will decrease the level or effect of sirolimus protein bound by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Omaveloxolone may reduce systemic exposure of sensitive CYP3A4 substrates. Check prescribing information of substrate if dosage modification is needed.  "
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Stomatitis",
            "percent": "79"
        },
        {
            "name": "Fatigue",
            "percent": "68"
        },
        {
            "name": "Infections",
            "percent": "59"
        },
        {
            "name": "Edema",
            "percent": "50"
        },
        {
            "name": "Nausea",
            "percent": "50"
        },
        {
            "name": "Diarrhea",
            "percent": "47"
        },
        {
            "name": "Weight decreased",
            "percent": "47"
        },
        {
            "name": "Musculoskeletal pain",
            "percent": "47"
        },
        {
            "name": "Decrease appetite",
            "percent": "44"
        },
        {
            "name": "Cough",
            "percent": "35"
        },
        {
            "name": "Vomiting",
            "percent": "32"
        },
        {
            "name": "Dysgeusia",
            "percent": "32"
        },
        {
            "name": "Abdominal pain",
            "percent": "29"
        },
        {
            "name": "Headache",
            "percent": "29"
        },
        {
            "name": "Hypertension",
            "percent": "29"
        },
        {
            "name": "Constipation",
            "percent": "24"
        },
        {
            "name": "Pyrexia",
            "percent": "24"
        },
        {
            "name": "Hemorrhage",
            "percent": "24"
        },
        {
            "name": "Insomnia",
            "percent": "21"
        },
        {
            "name": "Pneumonitis",
            "percent": "18"
        },
        {
            "name": "Dry mouth",
            "percent": "15"
        },
        {
            "name": "Dehydration",
            "percent": "15"
        },
        {
            "name": "Peripheral neuropathy",
            "percent": "15"
        },
        {
            "name": "Hemorrhoids",
            "percent": "12"
        },
        {
            "name": "Dry skin",
            "percent": "12"
        },
        {
            "name": "Nail disorder",
            "percent": "12"
        },
        {
            "name": "Dizziness",
            "percent": "12"
        },
        {
            "name": "Dyspnea",
            "percent": "12"
        },
        {
            "name": "Vision blurred",
            "percent": "12"
        },
        {
            "name": "Decreased lymphocytes",
            "percent": "82"
        },
        {
            "name": "Increased creatinine",
            "percent": "82"
        },
        {
            "name": "Decreased hemoglobin",
            "percent": "68"
        },
        {
            "name": "Increased triglycerides",
            "percent": "52"
        },
        {
            "name": "Increased cholesterol",
            "percent": "48"
        },
        {
            "name": "Increased ALT",
            "percent": "47"
        },
        {
            "name": "Decreased potassium",
            "percent": "44"
        },
        {
            "name": "Decreased magnesium",
            "percent": "42"
        },
        {
            "name": "Decreased leukocytes",
            "percent": "41"
        },
        {
            "name": "Decreased neutrophils",
            "percent": "35"
        },
        {
            "name": "Decreased platelets",
            "percent": "35"
        },
        {
            "name": "Decreased albumin",
            "percent": "35"
        },
        {
            "name": "Increased AST",
            "percent": "32"
        },
        {
            "name": "Increased alkaline phosphatase",
            "percent": "29"
        },
        {
            "name": "Decreased sodium",
            "percent": "24"
        },
        {
            "name": "Decreased calcium",
            "percent": "15"
        },
        {
            "name": "Decreased glucose",
            "percent": "15"
        },
        {
            "name": "Decreased phosphate",
            "percent": "15"
        },
        {
            "name": "Increased lipase",
            "percent": "12"
        },
        {
            "name": "Increased glucose",
            "percent": "12"
        },
        {
            "name": "Increased sodium",
            "percent": "12"
        },
        {
            "name": "Stomatitis",
            "percent": "18"
        },
        {
            "name": "Infections",
            "percent": "12"
        },
        {
            "name": "Decreased lymphocytes",
            "percent": "21"
        },
        {
            "name": "Decreased potassium",
            "percent": "12"
        },
        {
            "name": "Increased glucose",
            "percent": "12"
        },
        {
            "name": "Abdominal pain",
            "percent": "6"
        },
        {
            "name": "Dehydration",
            "percent": "6"
        },
        {
            "name": "Diarrhea",
            "percent": "2.9"
        },
        {
            "name": "Vomiting",
            "percent": "2.9"
        },
        {
            "name": "Constipation",
            "percent": "2.9"
        },
        {
            "name": "Fatigue",
            "percent": "2.9"
        },
        {
            "name": "Edema",
            "percent": "2.9"
        },
        {
            "name": "Musculoskeletal pain",
            "percent": "2.9"
        },
        {
            "name": "Hypertension",
            "percent": "2.9"
        },
        {
            "name": "Hemorrhage",
            "percent": "2.9"
        },
        {
            "name": "Insomnia",
            "percent": "2.9"
        },
        {
            "name": "Decreased phosphate",
            "percent": "9"
        },
        {
            "name": "Increased lipase",
            "percent": "6"
        },
        {
            "name": "Increased cholesterol",
            "percent": "3"
        },
        {
            "name": "Decreased albumin",
            "percent": "2.9"
        },
        {
            "name": "Increased AST",
            "percent": "2.9"
        },
        {
            "name": "ALT",
            "percent": "2.9"
        },
        {
            "name": "Decreased sodium",
            "percent": null
        }
    ]
}